NASDAQ : FTRE
Fortrea Holdings Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 19.87 USD (Nov 2, 2026, 3:48 PM EST) · Market cap 1.92B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.93B |
| Enterprise Value | 2.83B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 96.50M |
| Shares Outstanding | 96.50M |
| Shares Change (YoY) | +4.20% |
| Shares Change (QoQ) | +6.75% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 105.17% |
| Float | 95.38M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 20.60 |
| PS Ratio | 0.72 |
| Forward PS | 0.71 |
| PB Ratio | 3.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.43 |
| P/OCF Ratio | 9.57 |
| PEG Ratio | 0.44 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.06 |
| EV / EBITDA | 23.96 |
| EV / EBIT | 62.47 |
| EV / FCF | 16.74 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.97 |
| Quick Ratio | 0.88 |
| Debt / Equity | 2.10 |
| Debt / EBITDA | 8.44 |
| Debt / FCF | 6.62 |
| Interest Coverage | 0.55 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -12.34% |
| Return on Assets (ROA) | 1.03% |
| Return on Invested Capital (ROIC) | 3.12% |
| Return on Capital Employed (ROCE) | 2.58% |
| Weighted Average Cost of Capital (WACC) | 11.46% |
| Revenue Per Employee | $190,479 |
| Profits Per Employee | -$4,907 |
| Employee Count | 14,000 |
| Asset Turnover | 0.97 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 16.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.91 |
| 52-Week Price Change | +91.40% |
| 50-Day Moving Average | 20.31 |
| 200-Day Moving Average | 15.72 |
| Relative Strength Index (RSI) | 41.10 |
| Average Volume (20 Days) | 2,160,662 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 7.68M |
| Short Previous Month | 12.56M |
| Short % of Shares Out | 7.95% |
| Short % of Float | 8.05% |
| Short Ratio (days to cover) | 4.32 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.67B |
| Gross Profit | 533.40M |
| Operating Income | 45.30M |
| Pretax Income | -52.70M |
| Net Income | -68.70M |
| EBITDA | 118.10M |
| EBIT | 45.30M |
| Loss Per Share | -$0.73 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 220.60M |
| Total Debt | 1.12B |
| Net Cash | -897.90M |
| Net Cash Per Share | -$9.30 |
| Equity (Book Value) | 532.30M |
| Book Value Per Share | 5.52 |
| Working Capital | -30.60M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 201.80M |
| Capital Expenditures | -32.80M |
| Depreciation & Amortization | 72.80M |
| Net Borrowing | -75.70M |
| Free Cash Flow | 169.00M |
| FCF Per Share | $1.75 |
Margins
| Measure | Value |
|---|
| Gross Margin | 20.00% |
| Operating Margin | 1.70% |
| Pretax Margin | -1.98% |
| Profit Margin | -2.58% |
| EBITDA Margin | 4.43% |
| EBIT Margin | 1.70% |
| FCF Margin | 6.34% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.20% |
| Shareholder Yield | -4.20% |
| Earnings Yield | -3.64% |
| FCF Yield | 8.75% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $23.63 |
| Price Target Difference | 18.03% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 1.97% |
| EPS Growth Forecast (3Y) | 47.46% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 0.65 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |